PIK3CA, phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha, 5290
N. diseases: 1511; N. variants: 83
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.763 | 0.280 | 3 | 179148620 | intron variant | C/T | snv | 0.18 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.763 | 0.280 | 3 | 179148620 | intron variant | C/T | snv | 0.18 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.763 | 0.280 | 3 | 179148620 | intron variant | C/T | snv | 0.18 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.763 | 0.280 | 3 | 179148620 | intron variant | C/T | snv | 0.18 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.763 | 0.280 | 3 | 179148620 | intron variant | C/T | snv | 0.18 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.763 | 0.280 | 3 | 179148620 | intron variant | C/T | snv | 0.18 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.763 | 0.280 | 3 | 179148620 | intron variant | C/T | snv | 0.18 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.763 | 0.280 | 3 | 179148620 | intron variant | C/T | snv | 0.18 |
|
Pathological Conditions, Signs and Symptoms; Neoplasms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.763 | 0.280 | 3 | 179148620 | intron variant | C/T | snv | 0.18 |
|
Digestive System Diseases; Neoplasms | 0.010 | < 0.001 | 1 | 2015 | 2015 | |||||||
|
0.763 | 0.280 | 3 | 179148620 | intron variant | C/T | snv | 0.18 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.763 | 0.280 | 3 | 179148620 | intron variant | C/T | snv | 0.18 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.040 | 3 | 179157086 | intron variant | C/T | snv | 0.26 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
1.000 | 0.040 | 3 | 179160189 | intron variant | G/A | snv | 0.10 |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
3 | 179166120 | intron variant | T/C | snv | 7.1E-02 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
3 | 179166549 | intron variant | C/T | snv | 0.19 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
3 | 179169844 | intron variant | A/G | snv | 2.8E-02 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.925 | 0.080 | 3 | 179169899 | intron variant | G/A | snv | 0.25 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.925 | 0.080 | 3 | 179169899 | intron variant | G/A | snv | 0.25 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.776 | 0.200 | 3 | 179179886 | intron variant | C/A | snv | 0.30 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.776 | 0.200 | 3 | 179179886 | intron variant | C/A | snv | 0.30 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.776 | 0.200 | 3 | 179179886 | intron variant | C/A | snv | 0.30 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.776 | 0.200 | 3 | 179179886 | intron variant | C/A | snv | 0.30 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.776 | 0.200 | 3 | 179179886 | intron variant | C/A | snv | 0.30 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.776 | 0.200 | 3 | 179179886 | intron variant | C/A | snv | 0.30 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.776 | 0.200 | 3 | 179179886 | intron variant | C/A | snv | 0.30 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 |